Evidence map›Paper›PMID 35155711›Full record

ArticleOrthopaedic journal of sports medicine2022

Presoaking ACL Grafts in Vancomycin Decreases the Frequency of Postoperative Septic Arthritis: A Cohort Study of 29,659 Patients, Systematic Review, and Meta-analysis From the SANTI Study Group.

Alessandro Carrozzo, Adnan Saithna, Alexandre Ferreira, Sylvain Guy, Lamine Chadli, Edoardo Monaco, Daniel Pérez-Prieto, Yoann Bohu, Thais Dutra Vieira, Bertrand Sonnery-Cottet

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Orthopaedic journal of sports medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06166381 (Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in Decreasing the Risk of Infection in ACL Reconstruction Surgery), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06166381 narecruitingnot on this mapstarted 2024, after this paper: background citation

Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in Decreasing the Risk of Infection in ACL Reconstruction Surgery: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of DuhokRan2024 to 2025Enrolled288ConditionsInfection, BacterialArmsParenteral Antibacterial Agents, Parenteral Antibacterial Agents plus Vancomycin pre-soaked graft
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alessandro CarrozzoCentre Orthopédique Santy, Lyon, France.
Adnan SaithnaAZBSC Orthopedics, Scottsdale, Arizona, USA.
Alexandre FerreiraCentre Orthopédique Santy, Lyon, France.
Sylvain GuyCentre Orthopédique Santy, Lyon, France.
Lamine ChadliCentre Orthopédique Santy, Lyon, France.
Edoardo MonacoOrthopaedic and Trauma Surgery Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Daniel Pérez-PrietoDepartment of Traumatology and Orthopaedic Surgery, Hospital del Mar, Autonomous University of Barcelona, Barcelona, Spain.
Yoann BohuClinique du Sport, Paris, France.
Thais Dutra VieiraCentre Orthopédique Santy, Lyon, France.
Bertrand Sonnery-CottetCentre Orthopédique Santy, Lyon, France.
Centre Orthopédique Santy · FRClinique du Sport · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPresoaking anterior cruciate ligament (ACL) grafts in vancomycin has been reported to reduce the occurrence of septic arthritis (SA). However, strong recommendations for its universal use have been precluded by concerns regarding the fragility of previous meta-analyses. PURPOSE: The primary objective was to investigate whether presoaking ACL grafts in vancomycin was associated with a reduction in the rate of SA in a large series of patients. The secondary objective was to perform an updated systematic review and meta-analysis to determine the efficacy of vancomycin in reducing the rate of SA. STUDY

designCohort study and systematic review; Level of evidence, 3.

methodsA retrospective analysis of patients who underwent primary ACL reconstruction (ACLR) at our institution was undertaken. Rates of postoperative SA were determined and analyzed according to whether patients had received grafts presoaked in vancomycin. A systematic review of the literature and meta-analysis was performed. Odds ratios (ORs) for the risk of SA were calculated according to the inverse variance approach. Results were presented using forest plots, funnel plots, and the fragility index.

resultsA total of 5300 patients underwent primary ACLR during the study period. The rate of SA was 0.34% (11/3228) in the control group and 0.05% (1/2072) in the presoaked group. There was a 5-fold greater risk of SA in patients who did not receive grafts presoaked in vancomycin (OR, 5.13 [95% CI, 1.16-48.30];

conclusionThe meta-analysis demonstrated that presoaking ACL grafts in vancomycin was associated with significant reductions in the rates of SA when all graft types were analyzed together. This finding held true specifically for hamstring tendon autografts. The fragility index of these findings allows for a strong recommendation for the universal use of vancomycin presoaking. However, it should be noted that only a trend toward reduced SA rates was demonstrated with presoaking bone-patellar tendon-bone autografts in vancomycin.

Indexed as

ACLanterior cruciate ligament reconstructionkneeligamentsseptic arthritisvancomycin

Identifiers

PMID35155711
PMCPMC8832611
OpenAlexW4210907905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.